PNC Financial Services Group’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-111
| Closed | -$2K | – | 4715 |
|
|
2021
Q4 | $2K | Buy |
+111
| New | +$2K | ﹤0.01% | 4194 |
|
|
2021
Q3 | – | Sell |
-4
| Closed | – | – | 4417 |
|
|
2021
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 4295 |
|
|
2021
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 4220 |
|
|
2020
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 4081 |
|
|
2020
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 4062 |
|
|
2020
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 4067 |
|
|
2020
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 4059 |
|
|
2019
Q4 | $2K | Hold |
4
| – | – | ﹤0.01% | 3813 |
|
|
2019
Q3 | $2K | Hold |
4
| – | – | ﹤0.01% | 3874 |
|
|
2019
Q2 | $2K | Hold |
4
| – | – | ﹤0.01% | 3890 |
|
|
2019
Q1 | $2K | Hold |
4
| – | – | ﹤0.01% | 3896 |
|
|
2018
Q4 | $2K | Hold |
4
| – | – | ﹤0.01% | 3880 |
|
|
2018
Q3 | $2K | Hold |
4
| – | – | ﹤0.01% | 3974 |
|
|
2018
Q2 | $2K | Buy |
4
+3
| +300% | +$1.5K | ﹤0.01% | 4001 |
|
|
2018
Q1 | $2K | Buy |
+1
| New | +$2K | ﹤0.01% | 4063 |
|